GenAhead Bio, ERS Genomics enter into CRISPR/Cas9 license agreement

GenAhead and ERS Genomics has announced a non-exclusive license agreement to provide GenAhead with access to ERS Genomic...

October 9, 2018 | Tuesday | News
Novan inks $11M deal with Japanese firm

US based pharmaceutical company Novan has announced an extended license agreement with Sato Pharmaceutical Co, a Japanes...

October 9, 2018 | Tuesday | News
Japan MHLW grants orphan designation to Axicabtagene Ciloleucel

Daiichi Sankyo Company, Limited has announced that axicabtagene ciloleucel (formerly KTE-C19) has been granted Orphan Dr...

October 8, 2018 | Monday | News
Orgenesis announces license agreement with HekaBio in Japan

Orgenesis, a manufacturer, service provider and developer of advanced cell therapies, has announced that it has entered ...

October 5, 2018 | Friday | News
Researchers develop rapid test for infectious diseases

Researchers from Eindhoven University of Technology (The Netherlands) and Keio University (Japan) have developed a pract...

October 4, 2018 | Thursday | News
Tasuku Honjo wins Nobel in medicine

Japanese scientist Tasuku Honjo has been awarded this year’s Nobel Prize in physiology or medicine, for his discov...

October 3, 2018 | Wednesday | News
Eisai receives FDA approval for antiepileptic drug

Eisai Co., Ltd. has announced that its U.S. subsidiary Eisai Inc. received approval from the U.S. Food and Drug Administ...

October 1, 2018 | Monday | News
GHIT Fund invests in innovative TB diagnostics tools

The Global Health Innovative Technology (GHIT) Fund, Japan recently announced an investment of approximately 420 million...

September 27, 2018 | Thursday | News
PeptiDream announces agreement with Santen Pharmaceutical

Peptidream Inc., a public Kanagawa-based biopharmaceutical company has announced that it has entered into a broad-based ...

September 26, 2018 | Wednesday | News
Anaeropharma Science signs research agreement with Astellas

Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Ast...

September 25, 2018 | Tuesday | News
Takeda gets positive CHMP opinion for ALUNBRIG

Takeda Pharmaceutical Company Limited has announced that the European Medicines Agency’s (EMA) Committee for Medic...

September 24, 2018 | Monday | News
Mylan, Fujifilm receive European marketing authorization for Hulio Biosimilar

Mylan  and Fujifilm Kyowa Kirin Biologics recently announced that the European Commission (EC) has granted mar...

September 24, 2018 | Monday | News
Medtronic starts Onyx ONE Clear study in Japan and US

Medtronic has initiated a new clinical study in patients implanted with its Resolute Onyx drug-eluting stent (DES) durin...

September 14, 2018 | Friday | News
NEGTEC via crowdfunding portal promotes regenerative medicine

NEGTEC, an originator of the Sakura Bloom (SKB) cryptocurrency project, has announced a new donation-based crowdfunding ...

September 4, 2018 | Tuesday | News
Chugai, Nippon Shinyaku bring Gazyva in Japan

Tokyo based Chugai Pharmaceutical and Nippon Shinyaku have launched Gazyva (obinutuzumab), an anti-CD20 monoclonal antib...

August 30, 2018 | Thursday | News
Nissui Pharmaceutical Launches Colony Counter Service Based on AI Technology

Nissui Pharmaceutical Co., Ltd. is carrying out the trial operation to count colonies cultured in the "simple culture me...

August 30, 2018 | Thursday | News
Astellas announces approval of Linzess Tablets in Japan

Astellas Pharma and Ironwood Pharmaceuticals, recently announced that approval has been obtained in Japan for the guanyl...

August 27, 2018 | Monday | News
Rakuten Aspyrian raises $150M in Series C Financing

Tokyo-headquartered e-commerce group Rakuten Inc’s CEO and chairman of Rakuten Aspyrian Hiroshi Mikitani has led a...

August 27, 2018 | Monday | News